Physician

Stewart T Landau, MD

According to 2025 Medicare claims, Stewart Landau, MD (NPI: 1174559728) practices urology in the Provo-Orem-Lehi, UT market, with the plurality of this provider's patient population coming from Utah, UT. This provider's primary affiliated billing organization is GRANGER MEDICAL CLINIC PC (NPI: 1184657041; TIN: 870284475) and primary practice location at 84119-3602. Landau is affiliated with the Aledade 57 Western Sky MSSP Enhanced (ACO ID: A4756), Aledade 201 National MSSP (ACO ID: A5522), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Landau's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 98 traditional Medicare patients, billed 5,840 HCPCS/CPT codes, and received $362,392 in Medicare payments. The top billing code was J9217 (Leuprolide acetate (for depot suspension), 7.5 mg). Part D data shows 950 prescription claims across 122 beneficiaries totaling $7,921,731 in drug costs, led by Xtandi (Enzalutamide). 2022 DME data shows 15 claims. Open Payments data shows 87 records totaling $2,651. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $55,643 to $7,921,731. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	348	2,009	$164,543
2016	307	1,245	$122,447
2017	295	1,690	$124,894
2018	267	1,372	$114,672
2019	253	1,332	$110,866
2020	237	4,009	$717,245
2021	235	4,809	$848,500
2022	175	3,749	$1,252,400
2023	91	9,332	$496,167
2024	98	5,840	$362,392

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	201	568	$55,643
2016	191	546	$57,045
2017	202	522	$56,600
2018	164	457	$67,058
2019	187	635	$54,845
2020	198	728	$204,539
2021	195	637	$2,312,819
2022	182	727	$3,785,436
2023	122	627	$5,105,040
2024	122	950	$7,921,731

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	45	$5,479
2016	N/R	32	$3,717
2017	N/R	15	$3,902
2018	N/R	N/R	N/R
2019	N/R	16	$4,502
2020	N/R	42	$6,846
2021	N/R	51	$7,351
2022	N/R	15	$5,364
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	58	400	$139
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	48	66	$123
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	66	130	$84
96402	Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle	57	124	$26
96372	Injection of drug or substance under skin or into muscle	33	58	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	486	14,580	$6,723,247
Erleada	Apalutamide	57	1,710	$794,323
Orgovyx	Relugolix	151	4,530	$395,866
Ibandronate Sodium	Ibandronate Sodium	177	14,436	$5,314
Megestrol Acetate	Megestrol Acetate	44	3,670	$2,279

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	87	$2,651	Dendreon Pharmaceuticals LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Stewart T. Landau, MD?

Tedicare shows public-source Medicare data for Stewart T. Landau, MD (NPI 1174559728), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Stewart T. Landau, MD have ACO affiliation data?

Stewart T. Landau, MD is shown with ACO affiliation data for Aledade 57 Western Sky MSSP Enhanced (MSSP, ACO ID A4756), Aledade 201 National MSSP (MSSP, ACO ID A5522), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Stewart T. Landau, MD?

Stewart T. Landau, MD is linked to GRANGER MEDICAL CLINIC PC (billing NPI 1184657041) in the available physician profile data.

Does Stewart T. Landau, MD have Open Payments data?

Stewart T. Landau, MD has 87 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.